Diabetes mellitus is a common endocrinopathy in companion animals, characterised by hyperglycaemia, glycosuria and weight loss, resulting from an absolute or relative deficiency in the pancreatic hormone insulin. There are breed differences in susceptibility to diabetes mellitus in dogs, with the Samoyed breed being overrepresented, while Boxers are relatively absent in the UK population of diabetic dogs, suggesting that genetic factors play an important role in determining susceptibility to the disease. A number of genes, linked with susceptibility to diabetes mellitus in humans, are associated with an increased risk of diabetes mellitus in dogs, some of which appear to be relatively breed-specific. Diabetes mellitus in dogs has been associated with major histocompatibility complex (MHC) class II genes (dog leucocyte antigen; DLA), with similar haplotypes and genotypes being identified in the most susceptible breeds. A region containing a variable number of tandem repeats (VNTR) and several polymorphisms have been identified in the canine insulin gene, with some alleles associated with susceptibility or resistance to diabetes mellitus in a breed-specific manner. Polymorphisms in the canine CTLA4 promoter and in other immune response genes are associated with susceptibility to diabetes mellitus in a number of pedigree breeds. Genome wide association studies are currently underway that should shed further light on the genetic factors responsible for the breed profile seen in the diabetic dog population.
Introduction
Diabetes mellitus is a common endocrine disorder of dogs that occurs due to a failure to adequately control blood glucose, leading to hyperglycaemia, glycosuria and weight loss. Although the clinical presentation is similar in most cases, with polyuria and polydipsia being the most common clinical signs, canine diabetes mellitus is a heterogeneous disorder with several pathological mechanisms potentially leading to hyperglycaemia and the metabolic consequences that ensue. Virtually all diabetic dogs require exogenous insulin therapy to manage their hyperglycaemia, as a result of a deficiency in production of endogenous insulin. Thus, diabetes mellitus in dogs is considered to occur as the result of a 'type 1' pathogenesis of disease but, unlike the situation in human type 1 diabetes (T1D), which occurs primarily in adolescence and early adulthood, most cases of canine diabetes mellitus occur in middle-aged and older dogs . The underlying cause of pancreatic b cell dysfunction/destruction in dogs remains to be fully established, although exocrine pancreatic disease (Watson et al., 2010; Pápa et al., 2011) and/or immunemediated mechanisms are thought to be involved. It has been proposed that, in many ways, canine diabetes mellitus resembles latent autoimmune diabetes of adults (LADA) in humans (Fleeman and Rand, 2001; Andersen et al., 2010) .
Although a degree of insulin resistance and impaired glycaemic control occurs in obese dogs (Verkest et al., 2011) , this rarely progresses to overt diabetes mellitus, unless some other predisposing factor is also present, as seen in dioestrus diabetes (Wejdmark et al., 2011) . Thus, unlike the situation in cats (Scott-Moncrieff, 2010) , dogs do not seem to suffer from type 2 diabetes (T2D), the most common type of diabetes in the human population. Insulin resistance does occur in dogs, typically as a result of antagonism of insulin function by other hormones and most commonly during dioestrus or pregnancy (Fall et al., 2008 (Fall et al., , 2010 , where high levels of progesterone and growth hormone act as insulin antagonists (Eigenmann et al., 1983) . Similarly, diabetes mellitus can occur in dogs suffering from other endocrinopathies, e.g. hyperadrenocorticism (Blois et al., 2011) , where excessive cortisol production antagonises insulin activity.
Breed susceptibility to diabetes mellitus in dogs
There are differences in the breed profile of diabetic dog populations in different countries, which most likely is a result of regional differences in breed popularity, variability in genetic background of pedigree animals and cultural differences to elective neutering. In a Swedish population of diabetic dogs, there was an overrepresentation of some Scandinavian breeds, including the Swedish elkhound and Lapphund, with the majority reported to be female entire and thus likely to be suffering from dioestrus diabetes (Fall et al., 2007) . In the UK, where elective neutering is a more common practice, there is no sex predisposition (Davison et al., 2005) . The breed profile of dogs enrolled into the UK Canine Diabetes Register over the last 12 years (Table 1) is similar to that reported in the USA (Marmor et al., 1982; Hess et al., 2000; Guptill et al., 2003) . The Samoyed breed is consistently overrepresented in diabetic dog populations, whereas Boxer dogs seem to be particularly resistant to developing diabetes mellitus.
Although, in the majority of cases, the underlying pathogenesis of diabetes mellitus is not established, some breeds of dogs seem to be susceptible to specific types of diabetes mellitus. For example, Miniature schnauzer dogs suffer from idiopathic hyperlipidaemia, which could account for their increased risk of developing pancreatitis and diabetes mellitus (Whitney et al., 1993; Mori et al., 2010) . Similarly, some types of exocrine pancreatic disease are more common in German shepherd dogs (Westermarck et al., 2010) and Cocker spaniels (Watson et al., 2011) , which might predispose these breeds to diabetes mellitus, although the German shepherd is a relatively low risk breed and the Cocker spaniel has only moderate risk (Table 1) . Overall, there is no sex bias in the UK diabetic dog population, although there is a female predisposition to diabetes mellitus in Border collies, which has also been found in Sweden (Fall et al., 2007) , suggesting that this breed is more susceptible to dioestrus diabetes.
Differences in the breed prevalence of diabetes mellitus suggest that there are genetic factors that are involved in determining susceptibility to the disease. Some of the types of canine diabetes mellitus are somewhat similar to those seen in humans and, therefore, there might also be similarities in the specific genes that influence disease susceptibility. Alternatively, these could share a similar metabolic dysfunction and clinical manifestation, but occur through separate pathological processes, influenced by different genetic and environmental factors. Since some specific types of diabetes mellitus also seem to be breed related (e.g. neonatal diabetes predominantly in Labrador retrievers; Catchpole et al., 2008) , there might be differences in the specific susceptibility genes that contribute to the overall genetic risk, when comparing different breeds, which would be somewhat similar to the situation in humans, where some susceptibility genes are more important in specific ethnic groups (Noble et al., 2011) .
Genetics of diabetes mellitus in humans

Monogenic forms of diabetes mellitus
There are some types of diabetes mellitus that result from mutation(s) in a single gene. Monogenic forms of diabetes (neonatal diabetes mellitus, NDM; maturity onset diabetes of the young, MODY) account for 1-5% of human cases of diabetes mellitus (Steck and Winter, 2011) . Neonatal diabetes mellitus usually occurs in the first 6 months of life and can result from inherited (autosomal dominant) or sporadic (de novo) activating mutations in pancreatic b cell response genes. Mutations in KCNJ11 or ABCC8 genes that encode the two subunits of the b cell adenosine triphosphate (ATP)-sensitive potassium channel account for around 40% of cases (Edghill et al., 2008) . Of the remainder, autosomal dominant mutations in the insulin (INS) gene (Edghill et al., 2008; Støy et al., 2010) and autosomal recessive mutations in the glucokinase (GCK) gene (Hussain, 2010) can also lead to NDM in some cases.
Maturity-onset diabetes of the young (MODY) represents a group of disorders, typically seen in individuals under 25 years of age, caused by autosomal dominant mutations in genes that control either synthesis or secretion of insulin by pancreatic b cells. These include GCK (MODY2; $20-50% of cases), hepatocyte (Ellard, 2000; Steck and Winter, 2011) . With advances in molecular genotyping, the number of genes and mutations involved in causing NDM and MODY are increasing, although there remains a proportion of individuals where these are, as yet, undetermined.
Genetics of human type 1 diabetes mellitus and latent autoimmune diabetes of adults
Much is known about the genetics of human T1D and there is a web resource available (T1DBase 1 ) that integrates genetic, genomic and expression data across mice, rats and humans (Burren et al., 2011) . Considering the pathogenesis of disease in T1D and the role that autoimmunity plays in destruction of pancreatic b cells, it is perhaps not surprising that several immune-response genes have been implicated (Steck and Rewers, 2011) . Around 30-50% of the overall genetic risk of T1D maps to the region of chromosome 6 (IDDM1) containing human leucocyte antigen (HLA) genes (Todd et al., 1987) . Several studies have demonstrated an association between HLA-DR3-DQ2 (HLA-DRB1 
03:01-DQB1
Ã 03:02) and susceptibility to T1D in the Caucasian population (Erlich et al., 2008; Noble et al., 2011) . The molecular basis for this HLA association is believed to arise from differences in amino acid sequences around the peptidebinding groove of major histocompatibility complex (MHC) class II molecules. Increased susceptibility to diabetes mellitus has been linked to the presence of an amino acid other than aspartic acid at position 57 of the HLA-DQ b chain (Todd et al., 1987) and also with the presence of arginine at position 52 of the HLA-DQ a chain (Khalil et al., 1990) . Heterozygous (HLA-DR3-DQ2/DR4-DQ8) individuals are at greatest risk of developing T1D, which has been proposed to be due to formation of heterodimers encoded by the HLA-DQA1 Ã 05:01 allele of the HLA-DQ2 haplotype and the HLA-DQB1
Ã 03:02 allele of the HLA-DQ8 haplotype that are more effective in presenting diabetogenic self peptides (Khalil et al., 1992) .
Comparing different ethnic groups, there is a degree of variability in the specific HLA-types associated with T1D, e.g. 
HLA-DRB1
03:01-DQB1
Ã 03:03 are typically overrepresented in Japanese and East-Asian T1D populations (Ikegami et al., 2006) , whereas the HLA-DRB1
Ã 02:01 haplotype is associated with increased susceptibility to T1D in African Americans (Noble et al., 2011) . In contrast, other HLA genotypes are protective across several ethnic groups, e.g. a HLA-DQ6 haplotype (HLA-DQA1
Ã 01:02-DQB1 Ã 06:02) is present in both Caucasian and East-Asian populations that is negatively associated with susceptibility to T1D (Kawabata et al., 2002; Erlich et al., 2008) .
A number of other immune response genes have been implicated in T1D, including CTLA4 (IDDM12), PTPN22, IL2RA, IL12B, IL10 and IL2/IL21 (Steck and Rewers, 2011) . These genes influence various aspects of T cell biology and could play an important role in determining activation, differentiation and effector function of pathogenic T cells, as well as influencing tolerance mechanisms, such as clonal anergy and active suppression by regulatory T cells.
In terms of susceptibility genes not directly involved in the immune response, the INS gene (IDDM2) is probably the most important and confers $10% of the total genetic risk (Bennett et al., 1995) . As well as containing a number of single nucleotide polymorphisms (SNPs) (Støy et al., 2010) , there is a variable number of tandem repeats (VNTR), located in the INS promoter region, characterised by a repeating sequence with the consensus 5 0 -ACA-GGGGTSYGGGG-3 0 (Bell et al., 1984) . are associated with susceptibility to T1D, whereas long VNTR alleles (140-210 repeats) are protective. It has been shown that variability in the INS promoter VNTR can influence gene expression in the thymus, with short alleles generating significantly less insulin mRNA (Pugliese et al., 1997) . Variation in expression of this self antigen in primary lymphoid tissue might affect central tolerance mechanisms and thus influence clonal deletion of insulin-autoreactive T cells and/or production of insulin-specific regulatory T cells (Durinovic-Belló et al., 2012) .
Similar genes have been shown to be associated with susceptibility to T1D and LADA, suggesting similarities in pathogenesis (Grant et al., 2010) . LADA may represent a more slowly progressive form of autoimmune b cell destruction compared to the more acute form in T1D (Tuomi et al., 1993) . The HLA-DR3-DQ2 and HLA-DR4-DQ8 susceptibility haplotypes have shown similar associations in LADA, with heterozygous individuals being most at risk (Desai et al., 2007; Cervin et al., 2008) , although there are some differences in HLA profiles comparing T1D and LADA populations (Andersen et al., 2010) .
Both CTLA4 (Douroudis et al., 2009 ) and PTPN22 (Cervin et al., 2008) have been reported to be susceptibility genes for LADA, although there is a degree of inconsistency, depending upon the ethnic group studied (Andersen et al., 2010) . Similarly the INS VNTR has been strongly associated with LADA in some studies (Desai et al., 2006) but not in others (Andersen et al., 2010) . Interestingly, an association has been shown with the T2D susceptibility gene, transcription factor 7-like 2 (TCF7L2; Cervin et al., 2008; Szepietowska et al., 2010) , suggesting that T1D, LADA and T2D represents a spectrum of disease, with overlapping genetic factors, which perhaps justifies the alternative description of LADA as type 1.5 diabetes (Grant et al., 2010) .
Genetics of human type 2 diabetes and gestational diabetes
Some of the genes involved in monogenic diabetes mellitus (NDM and MODY) are also associated with susceptibility to T2D, suggesting that some genetic variants that have a less severe impact on gene expression and/or protein function might still lead to impaired glucose homeostasis (Florez, 2008) . Insulin resistance that develops as a consequence of metabolic changes in response to environmental or hormonal factors might cause clinical disease if there is also an underlying genetic defect in the insulin secretory capacity of pancreatic b cells. A polymorphism in KCNJ11 (E23K) is associated with increased activity of the b cell ATP-sensitive potassium channel, associated with impaired insulin secretion and a modest increased risk of T2D (Schwanstecher et al., 2002; Nielsen et al., 2003) . Thus, on their own, such polymorphisms might not be sufficient for progression to overt diabetes mellitus, unless additional environmental factors (e.g. obesity) are also present that have an impact on insulin sensitivity in peripheral tissues.
Candidate gene studies and genome-wide association studies in humans have identified a number of additional T2D susceptibility genes (Frayling, 2007; Florez, 2008) . Most of these T2D susceptibility genes influence insulin synthesis and/or secretion by b cells (e.g. TCF7L2, SLC30A8), whereas some others are more involved in influencing insulin sensitivity/metabolism in peripheral tissues (e.g. PPARG, FTO). The first reported T2D susceptibility gene, the peroxisome proliferator-activated receptor-c (PPARG) encodes a nuclear receptor that influences transcription of genes involved in regulation of glucose and fat metabolism (Altshuler et al., 2000) .
Subsequently, transcription factor 7-like 2 (TCF7L2) was identified as a T2D susceptibility gene in various ethnic groups (Grant et al., 2006; Cauchi et al., 2007) . This gene encodes a transcription factor that is involved in activation of glucagon-like peptide 1, which has several functions, including stimulation of insulin secretion after a meal, increasing pancreatic b cell mass and satiety (Liu and Habener, 2008; Vazquez-Roque et al., 2011) . It has also been suggested that TCF7L2 might have a more direct role in pancreatic b cell function and insulin processing (Loos et al., 2007) .
In 2007, a number of publications reported results of human genome-wide association studies highlighting several novel T2D susceptibility genes, most of which are associated with insulin production and/or secretion (Saxena et al., 2007; Scott et al., 2007; Sladek et al., 2007; Wellcome Trust Case Control Consortium, 2007) . One of these, solute carrier family 30 (zinc transporter) member 8 (SLC30A8), is a gene encoding an ion channel (ZnT8) that is important for insulin processing, storage and release in b cells (Pound et al., 2009) . A non-synonymous SNP in SLC30A8 (rs13266634; R325W) has been associated with susceptibility to T2D in various ethnic groups (Cauchi et al., 2010) .
The fat mass and obesity associated (FTO) and melanocortin 4 receptor (MC4R) genes have emerged as being associated with T2D, but whose function is not related to b cell function (Perry and Frayling, 2008) . These genes, expressed primarily in the hypothalamus, are believed to influence body mass index (BMI) through regulation of appetite, with individuals expressing obesity-associated genotypes also being at increased risk of developing T2D (Frayling, 2007) .
Gestational diabetes mellitus (GDM) is a heterogeneous disorder affecting 2-5% of women during pregnancy (Lambrinoudaki et al., 2010) . It is clear that the pathogenesis of GDM and T2D are somewhat similar, in that they are associated with a failure of pancreatic b cells to produce adequate amounts of insulin during a state of peripheral insulin resistance, resulting from metabolic and/or hormonal factors. At least 10 T2D susceptibility genes have also been linked to susceptibility to GDM, including KCNJ11, TCF7L2, SLC30A8 and FTO (Lauenborg et al., 2009; Petry, 2010) .
Genetics of diabetes mellitus in dogs
Monogenic diabetes mellitus in dogs?
Diabetes mellitus rarely occurs in dogs under 12 months of age, although NDM has been reported in several breeds, with histopathological changes consistent with congenital b cell aplasia/hypoplasia (Atkins et al., 1988 ). An inherited form of NDM, characterised by pancreatic b cell atrophy has also been reported in Keeshond dogs; although mating studies suggested an autosomal recessive mode of inheritance, the precise genetic defect has not been elucidated (Kramer et al., 1988) . Less than 10% of diabetic dogs in the UK Canine Diabetes Register were diagnosed under 7 years of age, although this 'juvenile' diabetic dog population is somewhat distinct in terms of its breed profile (Table 2) , with Labrador retrievers (odds ratio, OR = 17.1) and Golden retrievers (OR = 8.7) being overrepresented in the population of dogs that developed diabetes mellitus within the first year of life.
Screening for mutations/polymorphisms in canine KCNJ11 and INS genes has, so far, failed to reveal any genetic anomalies in this cohort of NDM dogs (unpublished data). There is little evidence for an autosomal dominant form of monogenic diabetes mellitus in dogs, suggesting that NDM/juvenile diabetes is possibly the result of autosomal recessive or spontaneous mutation(s) in, as yet, unidentified genes. Considering its role in human NDM and MODY (Steck and Winter, 2011) , glucokinase is a potential candidate gene, although the canine GCK sequence (XM_846042.2) is incomplete and its chromosomal location in the CanFam 3.1 Dog Genome Assembly 2 is currently unknown.
Dog leucocyte antigen (DLA) gene association with canine diabetes mellitus
Since MHC Class II genes are strongly associated with both T1D and LADA (Grant et al., 2010) , dog leucocyte antigen (DLA) genes were a logical choice for candidate gene studies. However, since there are differences in HLA susceptibility profiles comparing different ethnic groups of human diabetic patients (Erlich et al., 2008) , this needs to be taken into account when trying to identify MHC susceptibility alleles in relatively inbred populations of pedigree dogs.
A 
009-DQB1
Ã 001 ('DRB1 Ã 002' haplotype; OR = 1.51; CI = 1.03-2.19; P = 0.03) (Kennedy et al., 2006a) . In contrast, the DLA-DQA1 Ã 004-DQB1 Ã 013 haplotype was significantly reduced in frequency in the diabetic dog population (OR = 0.66; CI = 0.49-0.88; P < 0.005) and thus appeared to confer protection against diabetes mellitus (Kennedy et al., 2006a) .
Evaluation of DLA profiles within the most susceptible breeds (Samoyed, Tibetan terrier and Cairn terrier) and comparing these with the most diabetes resistant breeds (Boxer and German shepherd) has revealed some interesting similarities and differences. There is a specific haplotype in Samoyed dogs (DLA-DRB1 Ã 015-DQA1 Ã 006-DQB1 Ã 019:01/054:02) that is very similar to the high risk DLA-DRB1 Ã 015 haplotype, but which demonstrates two DQB1 alleles when DLA-typed from genomic DNA. Analysis of bloodderived mRNA from Samoyed dogs that are homozygous for this haplotype indicates that only the DLA-DQB1 (Stenström et al., 2002; Erlich et al., 2008) .
DLA-DQA1 alleles specifically encoding an arginine residue at position 55 of the a chain (DLA-DQ a Arg55), were shown to be increased in the diabetic dog population compared with controls (Kennedy et al., 2006a) , which is similar to the association with HLA-DQ a Arg52 in diabetes susceptibility in humans (Khalil et al., 1990) . However, upon further analysis of DLA-DQB1 alleles, there was no evidence for an association with the presence or absence of an aspartic acid residue at position 57 of the DLA-DQ b chain (Kennedy et al., 2006a) , unlike the situation in human T1D (Todd et al., 1987) . Within many of the other breeds at 'moderate risk' of developing diabetes mellitus (e.g. West Highland white terrier, Yorkshire terrier, Border terrier, Miniature poodle), the high risk DLA haplotypes were relatively uncommon or absent (Kennedy et al., 2006a) , suggesting that non-MHC genes might be more important in determining susceptibility to diabetes mellitus in these breeds. In Cocker spaniels, although this breed is relatively lacking in DLA diversity (Kennedy et al., 2002) , 51/54 diabetic dogs of this breed were homozygous for the DRB1 Ã 006:01-DQA1 Ã 005:011 haplotype. It has been suggested that Cocker spaniels are susceptible to developing an autoimmune type of pancreatitis that predisposes to diabetes mellitus (Watson et al., 2011) , which would be consistent with an overrepresentation of a specific DLA haplotype in affected animals.
A recent report has suggested that some disease association studies with DLA based on sequence-based typing might give anomalous results when compared to an alternative strategy of MHC genotyping using a SNP array targeting the classical MHC region (Safra et al., 2011) . Although this panel will be very useful for fine mapping the MHC region for other linked genes, it is likely that there are insufficient numbers of SNPs within the class II genes to differentiate between most DLA haplotypes because of the extensive diversity in these genes. Thus, the high density MHC SNP panel will help to identify associations with other MHC genes in this region that are much less polymorphic than class II, but will not necessarily replace DLA-typing.
It has also been suggested that, due the high degree of linkage disequilibrium within the MHC region, DLA associations might represent linked but not causative mutations/polymorphisms (Seddon et al., 2010) . In a study by Seddon et al. (2010) , where 60 diabetic dogs were genotyped using SNPs across a 14.6 kb region of the DLA centred on the DLA-DR and DLA-DQ loci, a region of fixed differences in SNPs was observed across the DQ region in dogs expressing the high risk DLA-DRB1 Ã 015 and DRB1 Ã 002 haplotypes, as well as the protective DLA-DQ haplotype, suggesting that a region outside exon 2 might be implicated. Furthermore, the authors reported that four novel DQB1 promoter alleles were seen exclusively in their diabetic dog population, as well as a substitution difference in the X1 box of the DQB1 promoter that could potentially modify the effect of the protective DQ haplotype (Seddon et al., 2010) .
Finally, it should be appreciated that MHC gene associations are not necessarily specific for diabetes mellitus and that similar DLA genotypes have been shown to be associated with susceptibility to other canine endocrinopathies, including hypothyroidism (Kennedy et al., 2006b ) and hypoadrenocorticism (Hughes et al., 2010) . Thus, DLA genes can be considered to be a general risk factor for immune-mediated disease, but other susceptibility genes might then influence the nature and target tissue of the pathological process that develops.
Insulin gene and susceptibility to canine diabetes mellitus
A total of nine SNPs (Fig. 1) Insulin gene polymorphisms exhibit breed-specific associations with canine diabetes mellitus (Short et al., 2007) . The INS c.-61C>T SNP (rs22686872) and a SNP downstream of the insulin gene (rs22686861; referred to as INS8) are associated with protection against diabetes mellitus in Cocker spaniels and Labrador retrievers, respectively, whereas the INS8 SNP is associated with an increased risk of diabetes mellitus in Jack Russell terriers (Short et al., 2007) . This suggests that, if the canine INS gene is involved in susceptibility to diabetes mellitus, the relationship is complex and breed specific. It has also been suggested that the adjacent IGF2 gene might also play a role in diabetes susceptibility (Short et al., 2007) .
Although no VNTR is present in the canine INS promoter, such a region (consensus 5 0 -GCCCCCGCC-3 0 ) can be found at the 5 0 end of intron 2 (Fig. 1) . A possible association between the INS VNTR and canine diabetes mellitus was investigated by genotyping the most susceptible breeds, Samoyed (n = 31 cases; n = 45 controls), Tibetan terrier (n = 33 cases; n = 31 controls) and Cairn terrier (n = 30 cases; n = 38 controls), and those resistant to the disease, Boxer, German shepherd and Golden retriever (n = 30 for each breed). The INS
VNTR2
allele was more common in the diabetes susceptible breeds than in the diabetes resistant breeds (P = 0.011; Fig. 2 ). The diabetes susceptible breeds, as a group, demonstrated a somewhat different genotype profile in comparison with the resistant breeds, with a greater number of INS VNTR2 homozygous animals seen in the diabetes susceptible population (P = 0.046; Fig. 2 ). This difference in INS VNTR alleles and genotypes was most apparent when comparing the Samoyed with the Boxer, the breeds at the extremes of the diabetes susceptibility spectrum (P < 0.01; Fig. 2 ). However, a case:control study within each of the diabetes susceptible breeds failed to reveal any association (unpublished data). Thus, there is little evidence to date that the canine INS VNTR plays a significant role in susceptibility to diabetes mellitus in these high risk breeds. both diabetic cases and controls. Inclusion criteria for control dogs were P6 years of age, with normal blood glucose concentrations. Cases were classified as diabetic based on reported history and clinical signs, and with compatible laboratory indices (hyperglycaemia, elevated serum fructosamine and haemoglobin A1c). Female entire diabetic dogs suffering from dioestrus diabetes were excluded from the study. Genomic DNA from diabetes resistant breeds (Boxer, German shepherd and Golden retriever; n = 30 each breed) and diabetes susceptible breeds (Samoyed: n = 31 cases, n = 45 controls; Tibetan terrier: n = 33 cases, n = 31 controls; Cairn terrier: n = 30 cases, n = 38 controls) were genotyped for the CANFA_INS VNTR. Genotype frequencies and allele frequencies are shown comparing the two groups of breeds and specifically comparing the highest risk (Samoyed) and lowest risk (Boxer) breeds (P values indicate statistical significance of differences).
It is possible that the canine insulin gene does contribute to susceptibility/resistance to diabetes mellitus in dogs, but this might only be apparent in specific breeds, as demonstrated by Short et al. (2007) , and it might be more important as a risk factor in those moderate risk breeds, in which DLA genes seem to play less of a role.
CTLA4 and other immune response genes in susceptibility to canine diabetes mellitus
Sequencing of the canine CTLA4 gene has revealed a remarkable amount of variation within the 1.5 kb promoter region, in which 15 SNPS and two internal deletions (indels) have been reported (Short et al., 2010) . A further four SNPs and an additional indel have now been identified in this region (unpublished data). The À318C/T SNP in the human CTLA4 promoter has been associated with T1D (Anjos et al., 2004) and LADA (Douroudis et al., 2009 ). Canine CTLA4 promoter polymorphisms were associated with diabetes mellitus in the Samoyed, Miniature schnauzer, West Highland white terrier, Border terrier and Labrador retriever (Short et al., 2010) . One haplotype (designated haplotype 8), was identified in 23% of diabetic Samoyed dogs (n = 40; P = 0.028), but was absent in non-diabetic control dogs of this breed (n = 18). Haplotype 8, comprising 15 SNPs, is virtually the allelic opposite of haplotype 3, the CTLA4 promoter variant typically present in Boxer dogs, the most diabetes resistant breed. Another haplotype (designated haplotype 12) was protective in Samoyed dogs, being present in 94% of controls and 69% of cases (P = 0.028).
Analysis of other canine immune response genes has revealed substantial within-breed differences in allele frequencies and a diverse range of breed-specific associations (Short et al., 2007 (Short et al., , 2009 ; of the genes investigated, IL6 SNPs were associated with diabetes mellitus in Miniature poodles and Yorkshire terriers, IL4 SNPs were associated with an increased risk of diabetes mellitus in Cairn terriers and Miniature schnauzers, and a specific IL10 diabetes susceptibility haplotype was identified in Cavalier King Charles spaniels. In contrast, none of the cytokine gene polymorphisms examined showed any association with diabetes mellitus in the Samoyed breed. It is likely that canine diabetes mellitus is a complex genetic disorder, where several susceptibility genes contribute to the overall genetic risk in a breed-specific manner. In Samoyeds, where high-risk DLA genotypes and particular CTLA4 promoter variants are common and are likely to contribute to this breed's intrinsically high risk of developing the disease, it is possible that additional contributory effects of cytokine gene polymorphisms are less important. Further studies are required to determine whether some diabetes susceptibility genes are common to disease susceptibility, or are shared across several different breeds, and which genes are involved in determining susceptibility to diabetes mellitus only in specific breeds.
T2D susceptibility genes and canine diabetes mellitus
Since canine diabetes mellitus most resembles T1D/LADA and since obesity does not seem to be a major risk factor in dogs, T2D susceptibility genes have received little attention to date. However, recent advances in understanding the genetic basis of LADA and GDM suggest that some T2D susceptibility genes (e.g. KCNJ11, TCF7L2, GCK and SLC30A8) deserve further investigation in canine diabetes mellitus. In particular, in dioestrus diabetes, where breed susceptibility has been identified (e.g. Swedish elkhounds and Border collies), involvement of T2D susceptibility genes that influence pancreatic b cell function might explain a failure of glycaemic control during periods of hormone-induced peripheral insulin resistance, particularly when animals are also overweight. A genome-wide association study is underway to investigate the genetic basis of dioestrus diabetes 4 which hopefully will shed further light on this particular phenotype of canine diabetes mellitus.
Conclusions
Canine diabetes mellitus is a heterogeneous disease and, in the majority of cases, the underlying pathogenesis of disease is not established, although insulin deficiency is a consistent feature. The presence of certain diabetes phenotypes, along with specific breed predisposition to these different types of diabetes mellitus, suggests an underlying genetic basis for disease susceptibility, but which might vary from breed to breed. Candidate gene studies so far have revealed some gene associations with the disease and ongoing genome-wide association studies are likely to identify novel loci that are involved in determining breed susceptibility to diabetes mellitus in dogs. At a time when 'one health/one medicine' is being emphasised, 5 studying diabetes mellitus in companion animals and the opportunities this presents in terms of comparative and translational research, might help to bridge the knowledge gap between understanding the pathophysiology and genetic basis of the disease and development of interventional therapies.
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